Market revenue in 2023 | USD 373.6 million |
Market revenue in 2030 | USD 575.9 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical diagnostics |
Fastest growing segment | Cannabis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Diagnostics, Pharmaceuticals, Microbiology, Cannabis |
Key market players worldwide | LGC Group, Bio-Rad Laboratories Inc, Randox, Merck KGaA, Randox Biosciences, QACS International, Weqas, BIPEA, NSI Lab Solutions, Absolute Standards, Instand |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory proficiency testing market will help companies and investors design strategic landscapes.
Clinical diagnostics was the largest segment with a revenue share of 33.65% in 2023. Horizon Databook has segmented the Europe laboratory proficiency testing market based on clinical diagnostics, pharmaceuticals, microbiology, cannabis covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held the second-highest share by revenue, following North America, and is estimated to exhibit a lucrative CAGR during the forecast period. Increase in research funding and the local presence of key market players in this region are expected to drive the market.
Moreover, organizations such as Eurachem are working toward promoting quality practices in the European region. It currently has 36 members from various countries in the region. The number of biopharmaceutical companies is increasing in Europe, owing to the increasing investments.
For instance, in 2017, USD 20 billion was raised as investment by the biopharma industry, which increased by 28% to USD 27.5 billion in 2019. A number of key players conduct their biopharmaceutical R&D activities in Europe.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe laboratory proficiency testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe laboratory proficiency testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account